Immunogenicity of the seven valent pneumococcal conjugate vaccine in patients with ataxia-telangiectasia.
Immune responses to a 7-valent pneumococcal conjugate vaccine were determined in 10 patients with ataxia-telangiectasia who are at high risk for pneumococcal disease because of immunodeficiency. Pneumococcal antibody titers for 7 serotypes measured increased 2.0- to 7.5-fold after immunization.
Schubert
Ralf
R
Department of Pediatrics, J W Goethe-University; Frankfurt/Main, Germany.
Reichenbach
Janine
J
Rose
Markus
M
Zielen
Stefan
S
D000293:Adolescent; D000328:Adult; D001260:Ataxia Telangiectasia / Q000276:immunology*; D001428:Bacterial Vaccines / Q000276:immunology*; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D011008:Pneumococcal Infections / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000276:immunology*; D011135:Polysaccharides, Bacterial; D018074:Vaccines, Conjugate
D001428:Bacterial Vaccines; D022242:Pneumococcal Vaccines; D011135:Polysaccharides, Bacterial; D018074:Vaccines, Conjugate